K9U-30525-32572 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-08-15
Dose 1 — Pfizer-BioNTech
Co-administered: Hepatitis B:Hib:Pneumonia:Rotavirus:Tetanus
2022-08-21
Registered in v-safe
2022-08-21
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Poor · Fever · Sleepiness, Irritability/crying

Under 3 check-in
2022-08-22
Health check-in — day 7, dose 1, under 3
Feeling: Poor · Fever · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site · Be unable to work or attend school

Under 3 check-in
2022-08-29
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-05
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-12
Health check-in — day 28, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-09-15
Dose 2 — Pfizer-BioNTech
2022-09-19
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Irritability/crying

Under 3 check-in
2022-09-20
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-21
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2022-09-22
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-29
Survey response — day 14, dose 2, under 3
MedDRA: Cough — Feeling: Fair

Free text: severe cough

MedDRA releases: 2024-11 · check-in free text available
2022-10-06
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-13
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-10-20
Survey response — day 35, dose 2, under 3
MedDRA: Influenza, Nasopharyngitis — Feeling: Fair · Be unable to work or attend school

Free text: cold/flu

MedDRA releases: 2024-11 · check-in free text available
2022-10-27
Health check-in — day 42, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-12-15
Survey response — 3 months, dose 2, under 3
MedDRA: Pyrexia — Feeling: Poor · Be unable to work or attend school

Free text: fever

MedDRA releases: 2024-11 · check-in free text available
2023-03-16
Health check-in — 6 months, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-08-15	Pfizer-BioNTech	Hepatitis B:Hib:Pneumonia:Rotavirus:Tetanus
2	2022-09-15	Pfizer-BioNTech	No

Free text

Release 12 (Under 3) — day 14, dose 2, under 3

2022-09-29

Symptoms: severe cough

Release 12 (Under 3) — day 35, dose 2, under 3

2022-10-20

Symptoms: cold/flu

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-12-15

Symptoms: fever

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Influenza	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Pyrexia	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release